Envista Holdings vs West Pharmaceutical Services
Envista Holdings and West Pharmaceutical Services are similar in size: $2.72bn and $3.07bn of revenue in their latest fiscal years. Envista Holdings grew faster (8.3% against 6.3%). West Pharmaceutical Services kept more of each dollar of sales as profit: a net margin of 16.1% against 1.7%. West Pharmaceutical Services carries less debt relative to equity (6.4% against 47.0%).
| Latest fiscal year | Envista HoldingsNVST, 2025 | West Pharmaceutical ServicesWST, 2025 |
|---|---|---|
| Revenue | $2.72bn | $3.07bn |
| Revenue growth | 8.3% | 6.3% |
| Net income | $47.0m | $494m |
| Operating margin | 7.9% | 19.0% |
| Net margin | 1.7% | 16.1% |
| Return on equity | 1.6% | 16.9% |
| Free cash flow | $230m | $469m |
| Cash | $1.21bn | $791m |
| Total debt | $1.46bn | $203m |
| Debt to equity | 47.0% | 6.4% |
| Dividend per share | — | $0.86 |
| Dividend yield | — | 0.2% |
| Share buybacks | $167m | $134m |
| Employees | 12,700 | — |
| Market value | $3.98bn | $28.63bn |
| Price vs our value range | Within our value range | Above our value range |
| Moat score | 48 (Moderate) | 77 (Strong) |
| Insider trades, 12 months | 0 buys, 3 sales | 0 buys, 8 sales |